Home NDC 0061-4305 NDC 0061-4305 - Resflor Gold This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0061-4305
Package NDCs from labels 0061-4305-01, 0061-4305-02, 0061-4305-03
Manufacturer Merck Sharp & Dohme Corp.
Effective date 2026-09-10
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Resflor GOLD ® Merck Sharp & Dohme Corp. 2026-09-10 PRESCRIPTION ANIMAL DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0061-4305-01 Resflor Gold 100 mL in 1 VIAL, MULTI-DOSE INJECTION 100 5 0061-4305-01 Resflor Gold 1 in 1 CARTON INJECTION 1 5 0061-4305-02 Resflor Gold 250 mL in 1 VIAL, MULTI-DOSE INJECTION 250 5 0061-4305-03 Resflor Gold 500 mL in 1 VIAL, MULTI-DOSE INJECTION 500 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0061-4305 RESFLOR GOLD (FLORFENICOL AND FLUNIXIN MEGLUMINE) INJECTION [MERCK SHARP & DOHME CORP.] 5 4 package rows 20241121_e622cfd8-2749-4a6f-b347-988806432c88.zip
DailyMed Socrata Ingredients# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.